Publication

Helicobacter pylori, Republic of Georgia

Downloadable Content

Persistent URL
Last modified
  • 05/21/2025
Type of Material
Authors
    Katrina Kretsinger, Emory UniversityJeremy Sobel, Centers for Disease Control and PreventionNato Tarkhashvili, National Center for Disease ControlNeli Chakvetadze, National Center for Disease ControlMarina Moistrafishvili, National Center for Disease ControlMerab Sikharulidze, National Center for Disease ControlBen D. Gold, Centers for Disease Control and PreventionMarina Chubinidze, National Center for Disease ControlPaata Imnadze, National Center for Disease Control
Language
  • English
Date
  • 2005-05-01
Publisher
  • CENTERS DISEASE CONTROL
Publication Version
Copyright Statement
  • 2005 CDC
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 11
Issue
  • 5
Start Page
  • 780
End Page
  • 781
Grant/Funding Information
  • Dr. Gold is supported in part by a grant from the National Institutes of Health, NIDDK (DK-53708).
  • This study was supported by a grant from the Biotechnology Engagement Program (BTEP) #13, Department of Health and Human Services.
Abstract
  • To the Editor: Helicobacter pylori infection is a principal cause of chronic active gastritis and peptic ulcer disease as well as gastric adenocarcinoma and mucosa-associated lymphoid tissue lymphoma (1). Poverty and crowding have been associated with infection epidemiologically (2,3). The Republic of Georgia has a per capita annual income of US $591, making it one of the poorest countries in the world (4,5). Georgia also reports a high annual incidence of gastric cancer, 17/100,000 population in 2002 (National Center for Disease Control, Tbilisi, unpub. data), which suggests an elevated prevalence of H. pylori infection. Testing and treatment for H. pylori are not practiced in this country, and diagnostic capacity for H. pylori is nonexistent. In October 2003, we conducted an exploratory pilot study of H. pylori infection to begin characterizing prevalence and risk factors for infection.
Author Notes
  • Jeremy Sobel, Centers for Disease Control and Prevention, 1600 Clifton Rd, Mailstop A38, Atlanta, GA 30333, USA; fax: 404-639-2205; email: jsobel@cdc.gov
Keywords
Research Categories
  • Health Sciences, Immunology

Tools

Relations

In Collection:

Items